Sphera Funds Management Ltd. Kura Oncology, Inc. Transaction History

Sphera Funds Management Ltd.

$382 Million
Q3 2025

A detailed history of Sphera Funds Management Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 245,522 shares of KURA stock, worth $2.75 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

245,522

Previous 235,522 4.25%

Holding current value

$2.75 Million

Previous $1.36 Million 59.94%

% of portfolio

0.57%

Previous 0.37%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$5.54 - $9.05 $55,400 - $90,500	10,000 Added 4.25%	245,522 $2.17 Million
Q2 2025 Aug 14, 2025	SELL	$5.55 - $6.92 $599,400 - $747,360	-108,000 Reduced 31.44%	235,522 $1.36 Million
Q1 2025 May 15, 2025	SELL	$6.6 - $9.05 $1.76 Million - $2.41 Million	-266,565 Reduced 43.69%	343,522 $2.27 Million
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $13,723 - $17,166	-739 Reduced 0.12%	610,087 $11.9 Million
Q1 2024 May 15, 2024	SELL	$13.42 - $23.53 $1.24 Million - $2.18 Million	-92,461 Reduced 13.15%	610,826 $13 Million

Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $844,000 - $1.19 Million	100,000 Added 16.58%	703,287 $6.41 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $481,950 - $657,000	45,000 Added 8.06%	603,287 $7.38 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $2.6 Million - $3.92 Million	-231,665 Reduced 29.33%	558,287 $6.93 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $3.55 Million - $5.74 Million	295,357 Added 59.72%	789,952 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $1.32 Million - $2.27 Million	-123,649 Reduced 20.0%	494,595 $9.07 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $2.52 Million - $3.63 Million	-213,994 Reduced 25.71%	618,244 $9.94 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $531,606 - $851,353	43,503 Added 5.52%	832,238 $11.7 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $1.24 Million - $1.74 Million	-80,151 Reduced 9.22%	788,735 $14.8 Million
Q2 2021 Aug 17, 2021	BUY	$20.85 - $29.88 $3.15 Million - $4.52 Million	151,135 Added 21.06%	868,886 $18.1 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $6.09 Million - $9.64 Million	246,257 Added 52.23%	717,751 $20.3 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $3.25 Million - $4.66 Million	112,000 Added 31.15%	471,494 $15.4 Million
Q3 2020 Nov 12, 2020	SELL	$16.3 - $30.64 $2.85 Million - $5.36 Million	-175,000 Reduced 32.74%	359,494 $11 Million
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $4.25 Million - $10.1 Million	534,494 New	534,494 $8.71 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $5.86 Million - $7.69 Million	-351,953 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$14.8 - $18.8 $324,904 - $412,716	21,953 Added 6.65%	351,953 $6.41 Million
Q1 2018 May 10, 2018	BUY	$14.5 - $23.4 $4.79 Million - $7.72 Million	330,000 New	330,000 $6.19 Million

Others Institutions Holding KURA

# of Institutions

214

Shares Held

81.2M

Call Options Held

900K

Put Options Held

228K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Kura Oncology, Inc. Transaction History